Lupin jumps after its arm incorporates wholly owned subsidiary in New Zealand

lupin surges on getting tentative usfda approval for mirabegron extended release tablets

Lupin is currently trading at Rs. 2062.00, up by 69.30 points or 3.48% from its previous closing of Rs. 1992.70 on the BSE. The scrip opened at Rs. 2014.00 and has touched a high and low of Rs. 2066.30 and Rs. 2004.00 respectively. So far 72851 shares were traded on the counter. The BSE group … Read more

BREAKING NEWS:
AC’s special mode saves energy and cools all night! “4-Star Safety: Affordable Family Cars at 3.5 Lakhs!” OnePlus 13 price slashed on Flipkart!